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    High blood pressure has become increasingly commonbetween people and also it takes a major risk factor 
for many diseases. The present study is done toperformthe collaborative care model in patients with high 
blood pressure. Hypertension is defined as: Systolic blood pressure (SBP) ≥140 mmHg or diastolic blood 
pressure (DBP) ≥90 mmHg .A collaborative care model is a native educating method based on patient's 
participation in the management of chronic disease. In this quasi-experimental study, 40 patients with high 
blood pressure (two equal groups of test and control) selected from two clinics in the city of Semnan in 
2013, and they were evaluated using the targeted and simple random sampling.The checklists included 
demographic information (5 items), medical and smoking history (13 items), anthropometric parameters (3 
items), laboratory measurements (6 items), diet (5 items), activities (7 items), dependent variables (5 items), 
cardiac complications (6 items), and frequency of doctor visits.The test group participated in intervention 
and participatory meetingsevery week. Collaborative care model, is comprised of4 stages; motivation, 
preparation, involvement, and evaluation over 3 months of intervention. Evaluation was based on the 
following criteria: Hypertensive patients(systolic blood pressure higher than 140 mmHg and diastolic blood 
pressureabove 90 mmHg, measured and approved in two different visits), to improvepatient health and 
knowledge, to decrease risk factors for disease,and to increase satisfaction and quality of health care services 
before and after intervention. Descriptive statistics, the independent t-test, and chi-square test were 
calculated at a significance level of 5%.Body mass index, triglyceride level, diastolic blood pressure, and 
salt intake declined in the test group after intermediation.Althoughthe consumption of bread and rice 
wasdecreased in the control group, but not in the test group.As previously described,performing the 
collaborative care model resulted in less catching high blood pressure, thus it can act as an efficient and cost-
effective method for preventing and controlling high blood pressure. 
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INTRODUCTION 
    Hypertension, or high blood pressure (HBP), 
represents the leading single risk factor for overall 
mortality and in getting many diseases globally 
[1,2]. In 2014, statistics indicatedthat more than 
26.6% of the Iranian population have got HBP, 
which is significantly higher than global statistics 
[3].A merethree mmHg reduction in systolic 
blood pressure can decrease mortality caused by 
coronary artery disease and cerebral apoplexy by 
5% and 8%, respectively [4].  
The need ofcontrolling HBP is of agreat 
importance [5]. The annual consensus conference 
reviewing the world literature, including JNC7 
program and the Cochrane database, has 
introduced lifestyle modification as a fundamental 
principle for HBP control [6]. In the other hand, 
Team-based approaches, which is composed of 
doctors and nurses can significantly enhance the 
quality oftaking care of the patients and, more 
importantly, prognoses [7]. Moreover, these 
methods allow doctors tosave extra time in order 
to do their duties perfectly [8]. Participation is the 
key to empower the patient's quality of life which 
is performed by training health providers [9]. The 
collaborative care model [10] was designed and 
utilized to control HBP for the first time in 2012. 
It is a native educating method based on 
 




participation that is especially applicable to 
nursing [11]. Because of the high prevalence of 
HBP in Semnan-Iran, the present study is done to 
investigate the effect of collaborative care model 
on controlling HBP in patients [12]. 
 
METHODS 
    This quasi-experimental study examined 40 
patients with HBPselected from two clinicsin the 
city ofSemnan in 2013. They were divided into 
test and control groups of equal size based on the 
same factors using targeted simple random 
sampling methods of encryption and random 
allocation. The criteria include: patients who have 
got HBP at least for 1 year and have records in the 
health centers. Also those who have no hearing 
and communication problems or patients who do 
not have an acute or advanced disease, such as 
cancer (that would affect the blood pressure 
control program)areincluded as criteria. In 
addition patient's willingness to participate in the 
intervention and repeated surveys 
withinthreemonths, was fully accented. 
Patients who became deceased or those were 
diagnosed with a new disease during the study 
were excluded. The data instruments were 
checklists containing demographic information (5 
items), medical and smoking history (13 items), 
anthropometric parameters (3 items), laboratory 
measurements (6 items), diet (including proteins, 
lipids, consumption of bread, rice, vegetables and 
fruits) and daily salt intake(5 items), activity (7 
items). The dependent variable checklistswerefor 
blood pressure during the 3 months of 
intervention, neurological symptoms and 
complications (5 items), cardiac symptoms and 
complications (6 items), frequencyof doctor visits, 
and hospitalization. The reliability and scientific 
validity of the questionnaire were confirmed by 
Cronbach's alpha at 0.76 and content validity, 
respectively.  
First, test and control group's checklists were 
distributed among patients and were completed 
separately by reach of them.Performing the 
collaborative care model in the test 
group,involvedintervention and participatory 
meetings each week to determine the conditions 
of the patients and the care team atTadayyon 
Health Center inSemnan.The stages of 
collaborative care modelimplementation, which 
lasted for three months, included phasesof 
motivation, preparation, involvement, and 
evaluation. The motivation phase was conducted 
in three sessions for a total of three hours to: (a) 
review and correct understanding of the 
conditions and problemsby help-seekers; (b) 
createequal awareness and understanding of the 
objectives; (c) familiarize members with their 
responsibilities in the care process; and 
(d)encourage the participants. 
Also, the preparation phase was conducted in two 
sessions to: (a) set objectives for care problems 
and diagnoses; (b) plan participatory education 
and follow-up visits to coordinate care problems 
with the diagnoses; (c) prepare care intervention 
programs; and (d) pursue care and treatment 
programs. The involvement phase was carried out 
in four visits. In the first visit, the groups were 
trained by doctors and nurses for a maximum of 
45 to 60 min after pressure control. After 
answering to questions, the time and place of the 
next visit were announced. Each training session 
was set up for fourgroups of fivepatientsfrom the 
intervention group. In the second visit, blood 
pressure was measured, issues raised in the 
previous session were reviewed, questions were 
plotted, the importance of proper recording of 
blood pressurewas taught, blood pressure record 
forms were handed out, and help-seekers were 
recommended to record their blood pressure at 
least once in a week. In the third, fourth and fifth 
visits, blood pressure was measured, issues from 
the previous meeting were reviewed, and 
questions were answered. In this 3-month period, 
the control group recorded blood pressure every 
month. Two participatory follow up meetings 
were held for the test group with the following 
goals: (a) determination of the primary 
responsibilities for the care and participatory 
team; (b) cooperation with the head of the group; 
and (c) training and follow-up visits. 
The evaluation stage was based on patient's health 
improvements and knowledge, reduction in the 
incidence of the HBP risk factors, and promotion 
in satisfaction and the quality of treatment 
services before and after intervention for both 
groups using the checklists. Data analysis was 
implemented by applying descriptive statistics, 
independent t-test, chi-square, and SPSS (version 
11) software with a significance level of 5%. 
 





     In this study, the test and control groups are 
included of 20 people with mean ages of 54.9 ± 
5.97 and 55.0 ± 5.78years (p = 0.398). The 
personal, social, and therapeutic characteristics of 
the participants are presented in Table and Figure 
1. There is a significant relationship between 
the two groups. In Table and Figure 2the effect 
of the collaborative care model is displayed for 
the intervention and control groups according to 
different parameters.  
The body mass index (BMI), triglyceride level, 
systolic and diastolic blood pressure 
significantly decreased in the test group after 
completion of intervention and increased in the 
control group. 
 
Table 1. the personal, social, and therapeutic characteristics of the participants 
 cases Controls  
n % n % p 
Sex Male 5 25 5 25 0.002 
Female 15 75 5 25 
 
marital status 
Married 11 55 14 70  
0.001 Single 1 5 0 0 
Widow 8 40 6 30 
education Primary 2 10 1 5  
0.001 Tips 7 35 4 20 
high School 11 55 15 72 
knowledge of 
thedisease 
Yes 11 55 10 50 0.002 
No 9 45 10 50 
treatment Yes 10 50 12 60 0.001 
No 10 50 8 40 
 
control level 
150-140 / 90-65 4 20 3 20  
0.023 160-150/95-90 14 70 13 65 
≥160/95 2 10 4 15 
chief complaint Headache 6 30 6 30  
0.042 Heartthrob 5 25 4 20 
Random 9 45 10 50 
Blood 
pressuredrugs 
Non 8 40 8 40  
0.025 ≤1 year 4 20 6 30 
>1 year 8 40 8 40 
pharmaceutical 
group 





beta-blockers 3 15 3 15 
alpha-blocker 1 5 0 0 
calciumchannelblockers 1 5 1 5 
Other 6 30 12 60 
underlying 
disease 




kidney failure 1 5 0 0 
Asthma 1 5 0 0 
Angina 2 10 0 0 
visual impairment 7 35 0 0 



















Table 2. Theeffect of the collaborative care model for the intervention and control groups according to different parameters 
 before after  
cases controls Cases controls 
means s.d means s.d means s.d means s.d p 
anthropometric Height 160.05 6.65 160.15 6.47 160.05 6.65 460.15 6.47 0.760 
Weight 75.73 11.69 65.05 15.77 72.05 11.93 66.60 9.21 0.155 
BMI 28.70 5.58 26.35 2.62 24.80 5.37 26.45 2.50 0.026 
laboratory cholesterol 298.15 483.06 185.10 39.81 161.35 32.93 184.65 52.08 0.068 
LDL 85.95 26.91 86.20 29.74 76.25 27.69 91.15 28.69 0.409 
HDL 45.80 7.90 44.35 8.01 50.35 10.19 46.15 8.42 0.149 
TG 166.00 46.91 160.90 44.55 139.95 32.34 163.40 50.02 0.010 
FBS 134.40 26.44 126.05 31.15 124.25 17.40 125.10 25.98 0.102 
diet Proteins 17.25 1.77 17.65 1.63 19.75 1.29 18.00 1.21 0.682 
Fats 10.05 1.50 10.30 1.38 9.95 1.54 10.50 1.39 0.399 
bread and 
rice 
3.00 0.00 3.05 0.22 3.00 0.00 2.85 0.67 0.041 
Vegetables 2.55 0.69 2.65 0.67 3.10 0.79 2.75 0.72 0.832 
Salt 2.80 0.77 2.50 0.83 1.05 0.22 2.50 0.83 0.001 
Activity 4.95 1.64 5.50 1.76 8.90 2.02 5.50 1.47 0.162 
blood pressure Systolic 165 7.77 158 9.51 139 8.97 152.5 12.61 0.254 
Diastolic 83.25 6.54 77.5 8.02 65 6.66 71.5 9.74 0.016 
 
 
Figure  1. The effect of the collaborative care model for the intervention and control groupsaccording to different parameters 
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But also no significant differences were seen in 
items such as eating vegetables, cereals and 
proteins in test group after intervention.  Bread 
and rice consumption did not change in the test 
group, but decreased in the control group. Salt 
intake significantly decreased in the intervention 
group, but no difference was observed for the 
control group. According to above, the 
collaborative care model will cause better control 
andless risk of catching high blood pressure by 




    To increase the effectiveness of preventive and 
therapeutic treatments of hypertension, health 
officials have suggested a variety of solutions, 
such as screening, providing advice to people at 
risk, and training and monitoring of the proper 
management of HBP risk factors [11, 13]. 
Moreover, monitoring HBP is necessary because 
of its prevalence[12]. As a result, the present 
study assessed the effect of collaborative care 
model on controlling or decreasing the risk of 
gettinghigh blood pressure in patients referred to 
health centers in Semnan. 
The results of several studies[11, 13-15] have 
shown that the association between drug 
treatments and methodssuch as collaborative care 
models significantly decreasesHBP in patients. A 
similar study used intervention with a 
collaborative care model that led to a significant 
reduction in diastolic blood pressure[16]. 
McConnell et al.[5]stated that collaborative care 
models lowered blood pressure by 16 mmHg in 
patients in the intervention group. But in our 
study, the described model caused an average of 
26mmHg decrease in blood pressure. Thus, as 
reported, the blood pressure decrease in our study 
is obviously more than McConnel's research.The 
reason, is the effectiveness of training for HBP, 
including lifestyle modification, more interactive 
care andpatient participation in HBP control, and 
increased awareness through a collaborative care 
model. 
Dean et al. [7] have shown that 53 percent of 
patients, do not have proper control on their blood 
pressure while they have received general 
educations for. That this percentage is more than 
our study. Authorshave believed variety of 
barriers in performing methods to control blood 
pressure as the essential reason for this issue. 
They pay little attention to attend to meetings 
with a physician, regarding the study as 
suspicious and distrustful plan, lack of 
information about the nature of the disease and its 
complications, and lack of adequate treatment[17-
19].Also, participation and education of HBP 
patients are important for controlling their blood 
pressure [8]. The results ofthe present study 
demonstrated that salt intake, triglyceride level, 
and BMI were the factors affecting HBP patients 
which were decreased significantly in those who 
underwent training. In addition to emphasis on a 
decrease in blood pressure using a collaborative 
care model, Mohammadi et al. [9] reporteda 
reduction in HDL and BMI levels, as 
well.Drabsch et al. [10] found that the use of 
team-centered models, based on following the 
guidelines were useful for controlling HBP and 
also recoveringpatients. 
The distinction of this study was that it's 
unprecedented in Iran and specially Semnan. 
According to a study by Ghorbaniet al. [12], the 
prevalence of HBP between adults inSemnan, was 
evaluated considerably high (44.2 in male and 
35.9 in female) and in more than 90% of the HBP 
cases, there were at least one of therisk factors of 
coronary diseases.Therefore, this study suggested 
to design some predictive and therapeutic plans in 
order to decrease the amount of HBP and its 
complications in this region. So, we were inspired 
to thinks of performing collaborative care model 
here in Semnan. 
This study attempted to assess the factors 
affecting HBP, including anthropometric 
parameters, laboratory parameters, nutritional 
indicators, and blood pressure indices in the 
intervention and control groups using the results 
of different studies when possible. Some 
limitations, such as the relatively small statistical 
sample size and restricted measurement 
instrument, cannot be overlooked. 
The results of this researchshowed that the use of 
a collaborative care model can be a beneficial, 
affordable and effective method for the 
prevention and control of HBP. Nevertheless, 
further studies are required by other researchers to 
confirm the results,forthe restrictions of this 
investigation. 
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